Students spend two years of the programme at one of the following A*STAR research institutes
The BII focuses on theoretical approaches aimed at understanding biomolecular mechanisms that underlie biological phenomena, the development of computational methods to support this discovery process, and experimental verification of predicted molecular and cellular functions of genes and proteins with biochemical methods.
BTI has core expertise in bioprocess science and engineering and has initiated new research programmes that will complement, add onto, as well as exploit existing capabilities.
The scientific focus of GIS is to investigate questions in the realm of functional genomics and integrative biology, exploiting the intersect between genomics, cell biology, and medicine and taking advantage of the contrasting genetic history of Pan-Asian populations to uncover fundamental truths. GIS' biological focuses on cancer biology, stem cell genomics, cellular pharmacology, and host-pathogen interactions are integrated with technology development in order to create novel solutions to difficult problems.
IBN is focused on generating new knowledge and creating innovative technology platforms that combine novel catalytic chemistry, biomaterials, nanofabricated devices, and microfluidic systems with biological and biomedical engineering.
IMCB has established itself as a premier molecular and cell biology institute, with a vision to remain a premier molecular biology and cell institute with increasing focus on addressing the mechanistic basis of human diseases.
The mandate of SIgN is to advance human immunology research and participate in international efforts to combat major health problems. Researchers at SIgN investigate immunity during infections and inflammatory conditions, including cancer, using both mouse models and human tissues.